Advances in understanding of fragile X pathogenesis and FMRP function, and in identification of X linked mental retardation genes.

Abstract

The fragile X mental retardation syndrome is caused by large methylated expansions of a CGG repeat in the FMR1 gene that lead to the loss of expression of FMRP, an RNA-binding protein. FMRP is proposed to act as a regulator of mRNA transport or translation that plays a role in synaptic maturation and function. The recent observations of unexpected phenotypes in some carriers of fragile X premutations suggest a pathological role, in these individuals, of an abnormal FMR1 mRNA. FMRP was recently shown to interact preferentially with mRNAs containing a G quartet structure. Mouse and Drosophila models are used to decipher the function of FMRP, which was found to inhibit translation of some mRNA targets, but may be stimulatory in other cases. Proteins interacting with FMRP have been identified, and suggest a link with the Rac1 GTPase pathway that is important in neuronal maturation. Recent advances also include identification of other genes implicated in X-linked mental retardation.

• Authors: Barbara Bardoni, Jean-Louis Mandel
• Journal: Current opinion in genetics & development (Curr Opin Genet Dev) Vol. 12 Issue 3 Pg. 284-93 (Jun 2002) ISSN: 0959-437X [Print] England
• PMID: 12076671 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review)

Chemical References

• FMR1 protein, human
• Nerve Tissue Proteins
• RNA-Binding Proteins
• Fragile X Mental Retardation Protein
• rho GTP-Binding Proteins

Topics

• Brain (metabolism)
• Fragile X Mental Retardation Protein
• Fragile X Syndrome (genetics)
• Humans
• Intellectual Disability (genetics)
• Mutation
• Nerve Tissue Proteins (genetics, metabolism)
• Phenotype
• RNA-Binding Proteins
• Trinucleotide Repeat Expansion
• rho GTP-Binding Proteins (metabolism)